Global HPV Testing Market 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights
• Cervical cancer diagnosis by HPV testing

PART 05: Market landscape

• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product

• Global HPV testing market by systems
• Global HPV testing market by consumables

PART 07: Market segmentation by end-user

• Hospitals
• Clinical diagnostic laboratories
• Physicians' office laboratories

PART 08: Geographical segmentation

• HPV testing market in Americas
• HPV testing market in EMEA
• HPV testing market in APAC

PART 09: Market drivers

• Early detection of cervical cancer to prevent the growing prevalence
• Paradigm shift toward use of HPV home-testing kits
• Reimbursements for HPV tests

PART 10: Impact of drivers

PART 11: Market challenges

• Pap test: Alternative diagnostic test for cervical cancer screening
• Limited number of health clinics and healthcare settings in developing countries
• Lack of uniformity in screening policies

PART 12: Impact of drivers and challenges

PART 13: Market trends

• Expansion of companies in key markets
• Co-testing with HPV and Pap tests
• Development of mRNA HPV test

PART 14: Vendor landscape

• Competitive landscape analysis

PART 15: Key vendor analysis

• Abbott Laboratories
• BD
• Roche Diagnostics
• Qiagen
• Hologic
• Other prominent vendors

PART 16: Appendix

• List of abbreviations

PART 17: Explore Technavio